PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 33 filers reported holding PDL BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $296,000 | +3.1% | 93,256 | -5.5% | 0.00% | -100.0% |
| Q2 2020 | $287,000 | +567.4% | 98,634 | +654.5% | 0.00% | – |
| Q4 2019 | $43,000 | +59.3% | 13,072 | +4.9% | 0.00% | – |
| Q3 2019 | $27,000 | -28.9% | 12,456 | +22.4% | 0.00% | – |
| Q1 2019 | $38,000 | -92.7% | 10,175 | -95.5% | 0.00% | -100.0% |
| Q1 2017 | $520,000 | -2.1% | 223,634 | -10.8% | 0.00% | 0.0% |
| Q4 2016 | $531,000 | -28.7% | 250,691 | +12.5% | 0.00% | -50.0% |
| Q3 2016 | $745,000 | +6.4% | 222,831 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $700,000 | -5.0% | 222,831 | +0.8% | 0.00% | 0.0% |
| Q1 2016 | $737,000 | -6.2% | 221,115 | +0.3% | 0.00% | 0.0% |
| Q4 2015 | $786,000 | -30.6% | 220,562 | -1.8% | 0.00% | -33.3% |
| Q3 2015 | $1,132,000 | -55.4% | 224,578 | -42.8% | 0.00% | -40.0% |
| Q2 2015 | $2,538,000 | +23.3% | 392,732 | +34.1% | 0.01% | +25.0% |
| Q1 2015 | $2,059,000 | – | 292,776 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Silver Point Capital L.P. | 23,783,273 | $58,745,000 | 6.82% |
| Park West Asset Management LLC | 14,397,212 | $35,561,000 | 0.74% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 633,700 | $1,565,000 | 0.24% |
| JBF Capital, Inc. | 543,990 | $1,344,000 | 0.22% |
| Context Capital Management, LLC | 465,172 | $1,149,000 | 0.16% |
| Bellecapital International Ltd. | 108,025 | $267,000 | 0.09% |
| FNY Investment Advisers, LLC | 100,000 | $247,000 | 0.07% |
| WINTON GROUP Ltd | 291,360 | $720,000 | 0.05% |
| Freedom Investment Management, Inc. | 54,735 | $135,000 | 0.02% |
| HANCOCK WHITNEY CORP | 187,757 | $464,000 | 0.02% |